References:
  1. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382(10), 929–936
  2. World Health Organization. WHO characterizes COVID-19 as a pandemic. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. Accessed February 1, 2021
  3. Youssef M, Hussein M, Attia AS, et al. COVID‐19 and liver dysfunction: A systematic review and meta‐analysis of retrospective studies. J Med Virol. 2020; 92: 1825– 1833
  4. Suresh Kumar VC, Harne PS, Mukherjee S, et al. Transaminitis is an indicator of mortality in patients with COVID-19: A retrospective cohort study. World J Hepatol. 2020:12(9), 619–627
  5. Zhang JJ, Lee KS, Ang LW, Leo YS, Young BE. Risk factors for severe disease and efficacy of treatment in patients infected with COVID-19: a systematic review, meta-analysis, and meta-regression analysis. Clin Infect Dis. 2020;71(16):2199-206
  6. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020;40(9):2095-2103
  7. Henry BM, Aggarwal G, Wong J, et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med. 2020;38(9):1722-1726
  8. Mendoza M, Garcia-Ruiz I, Maiz N, et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG. 2020;127(11):1374-1380
  9. Chen L., Li Q., Zheng D., Jiang H., Wei Y., Zou L. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. N Engl J Med. 2020;382:e100
  10. Deng G, Zeng F, Zhang L, Chen H, Chen X, Yin M. Characteristics of pregnant COVID-19 patients with liver injury. J Hepatol. 2020;73(4), 989-991
  11. Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020; 382:1708-1720
  12. Feng G, Zheng KI, Yan QQ, et al. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J Clin Transl Hepatol. 2020;8(1):18‐24
  13. Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019‐nCoV infection. BioRxiv. 2020 Feb 4. Online ahead of print
  14. Adams DH, Hubscher SG. Systemic viral infections and collateral damage in the liver. Am J Pathol. 2006;168(4), 1057–1059
  15. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11), 1061–1069
  16. Fan Z, Chen L, Li J, et al. Clinical Features of COVID-19-Related Liver Functional Abnormality. Clin Gastroenterol Hepatol. 2020;18(7), 1561–1566